Europlasma S.A., a company specializing in plasma solutions, renewable energies, and asbestos waste treatment, has been navigating a challenging financial landscape. Listed on the NYSE Euronext Paris, the company’s shares have experienced significant volatility over the past year. As of January 11, 2026, the share price closed at €0.1612, marking a stark contrast to its 52-week high of €82.50 on January 14, 2025. This dramatic decline underscores a long-term devaluation, with the stock trading near its lower bound for an extended period.
Founded in 1992 and headquartered in Pessac, France, Europlasma has been a key player in providing innovative solutions for gas and hazardous waste management, electricity production from waste and biomass gasification, and the destruction and valorization of asbestos waste. Despite its specialized services, the company’s financial performance has been underwhelming, as evidenced by its current market capitalization of €474,535 and a negative price-to-earnings ratio of -0.001.
In recent developments, Europlasma transferred €2 million to the Fonderie de Bretagne on December 5, 2025, with an outstanding €3 million due by the end of the year. This financial obligation highlights the company’s ongoing efforts to manage its liabilities amidst a challenging economic environment.
The significant disparity between Europlasma’s historical peak and its current trading levels suggests a prolonged period of financial instability. Investors and stakeholders are closely monitoring the company’s strategic initiatives to stabilize its financial standing and restore investor confidence. As Europlasma continues to navigate these challenges, its focus on innovative waste management solutions remains a critical component of its long-term strategy.
